midazolam has been researched along with parecoxib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feldman, J; Ibrahim, A; Karim, A; Kharasch, E | 1 |
| Bint, L; Czarniak, P; Landwehr, C; Parsons, R; Richardson, J; Sunderland, B | 1 |
1 trial(s) available for midazolam and parecoxib
| Article | Year |
|---|---|
The influence of parecoxib, a parenteral cyclooxygenase-2 specific inhibitor, on the pharmacokinetics and clinical effects of midazolam.
Topics: Adult; Area Under Curve; Biotransformation; Cyclooxygenase Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Double-Blind Method; Drug Interactions; Electroencephalography; Female; Half-Life; Humans; Hypnotics and Sedatives; Injections, Intravenous; Isoxazoles; Male; Midazolam; Mixed Function Oxygenases; Nausea; Reflex; Vomiting | 2002 |
1 other study(ies) available for midazolam and parecoxib
| Article | Year |
|---|---|
Cross-sectional survey of off-label and unlicensed prescribing for inpatients at a paediatric teaching hospital in Western Australia.
Topics: Australia; Child; Child, Preschool; Clonidine; Drug Administration Routes; Drug Prescriptions; Female; Humans; Inpatients; Isoxazoles; Legislation, Drug; Male; Midazolam; Off-Label Use; Oxycodone; Pediatrics | 2019 |